CBG vs CBD: How Cannabigerol Stacks Up Against Cannabidiol

CBG vs CBD is a comparison of two non-intoxicating cannabinoids with very different track records. CBD is a major cannabinoid in hemp and the active ingredient in a prescription medicine. CBG, or cannabigerol, forms from the plant's starting cannabinoid and usually shows up in much smaller amounts, and research on it is young. Here's how the two compare on chemistry, effects in the body, early research and Michigan law.

CBG in brief: the CBGA precursor story

So what is CBG, and where does it come from? Cannabis builds its main cannabinoids from one starting compound, cannabigerolic acid, or CBGA. Plant enzymes turn CBGA into the acid forms of other cannabinoids: THCA, CBDA and CBCA. Heat converts those acids into THC, CBD and CBC, and the same process turns any leftover CBGA into CBG. That's the story behind its nickname, the “mother of all cannabinoids.”

Since the plant converts most of its CBGA, typical cannabis carries little CBG: up to about 10% of its cannabinoid content, according to a 2022 review. Breeders have developed plants with less of the converting enzymes, pushing CBG as high as 90% of the cannabinoid fraction. Our explainer on what CBG is goes deeper, and our guide to CBC covers another cannabinoid that starts as CBGA.

CBD in brief

CBD, or cannabidiol, starts life in the plant as CBDA and is a major cannabinoid in many hemp plants. It doesn't produce a THC-style high, and it's far better studied than CBG. The FDA has approved one CBD product, a prescription medicine for seizures caused by three rare conditions: tuberous sclerosis complex, Dravet syndrome and Lennox-Gastaut syndrome. It's approved for patients as young as one. Over-the-counter CBD products haven't been through that review. For the fuller research picture, see our CBD benefits guide.

Key CBG and CBD differences: plant amounts, structure and receptors

How much the plant makes. CBD can be the dominant cannabinoid in hemp bred for it. CBG usually makes up a small share unless a plant was bred for it.

Structure. The two are close chemical relatives. Chemists describe CBG as a structural analogue of CBD: picture CBD with one of its rings opened up.

Receptors. CBG binds the body's CB1 and CB2 cannabinoid receptors only weakly, roughly 5 and 27 times less strongly than THC. In lab studies it also activates alpha-2 adrenergic receptors and partly blocks 5-HT1A serotonin receptors, which researchers think may explain much of its activity. CBD does little to activate CB1 directly and works through a long list of other targets.

How CBG and CBD interact with the body

Both compounds work partly through the endocannabinoid system, the body's own set of cannabinoid receptors and chemical messengers, which helps regulate processes such as pain, mood and immune responses. Our cannabinoid primer explains the basics.

CBG's lab profile is broad. Beyond CB1 and CB2, it acts on several TRP channels involved in sensation and inflammation, and on PPAR-gamma, a receptor tied to metabolism. It also slows FAAH, the enzyme that breaks down anandamide, one of the body's own cannabinoids, though less effectively than CBD does.

Most of this comes from cell and animal studies. How these actions play out in people, at the amounts in consumer products, is still an open question. A 2022 review called CBG one of the least-known cannabinoids and said its promise still needs thorough testing.

What CBG research explores: pain, mood and skin

Claims about CBG benefits run well ahead of the research, so read each finding as a lead, not a result.

What people report

The first survey of people using CBG-dominant cannabis, published in 2022, gathered answers from 127 adults. The most common reasons they gave were anxiety, chronic pain, depression and poor sleep, and most said their symptoms improved. The side effects they mentioned most were dry mouth, sleepiness, increased appetite and dry eyes. A survey records impressions; it can't show that CBG caused any change, and the authors called for randomized trials.

Mood and stress

In 2024, researchers ran what they described as the first clinical trial of CBG's short-term effects on anxiety, stress and mood. Thirty-four healthy adults took 20 mg of hemp-derived CBG or a placebo at home, a week apart. After CBG, they rated their anxiety and stress lower, did better on a verbal memory test and showed no sign of a high or impairment. The authors listed limits: a modest group of people without anxiety disorders, one modest dose and no correction for running many comparisons.

Later trials have been small, too. A 2026 study gave 12 healthy adults single doses of up to 200 mg and found CBG well tolerated, with few measurable effects. In a 2025 trial that assigned 63 veterans with sleep problems to CBG or a placebo for four weeks, sleep scores improved without a significant difference between the groups.

Pain and inflammation

Lab and animal studies have reported anti-inflammatory, antibacterial and antifungal activity for CBG, which is why it interests pain and inflammation researchers. Animal results don't reliably predict what happens in people, so read them as reasons for more research, not as evidence that CBG eases pain.

Skin and acne

Skin cells offer a neat contrast. In lab-grown human oil-gland cells, CBD has reduced excess oil production, the effect behind its interest for acne. A 2016 study of other cannabinoids found that CBG did the opposite and raised oil production, and its authors suggested CBG might suit dry skin instead. These were lab experiments, so they don't tell you how a CBG or CBD product would work on your skin.

If you're thinking about CBG or CBD for any health reason, talk with your clinician first, especially if you take medications.

Is CBG legal? Hemp-derived vs. marijuana-derived products

The law cares about THC, not CBG or CBD. Michigan classifies cannabis at or under 0.3% THC, with THCA included, as industrial hemp. Anything above that is marijuana, and only licensed marijuana businesses may sell it. A CBG or CBD product's legal category therefore depends on its THC, not its headline cannabinoid. Our hemp vs. marijuana explainer covers the line in detail.

Federal rules are shifting too. Congress's narrower hemp definition, which counts total THC including THCA, is set to take effect in late 2026, as of October 2026; further changes are possible. That could matter for hemp CBG and CBD products with trace THC.

Is CBG psychoactive? How it compares with CBD and THC

Neither CBG nor CBD intoxicates the way THC does. CBG's weak hold on the CB1 receptor, the one behind THC's high, helps explain why. In the 2024 trial, people who took 20 mg of CBG reported no drug high and showed no impairment. CBD doesn't produce a high either, though it can make some people drowsy.

Non-intoxicating doesn't mean THC-free. Full-spectrum products keep small amounts of THC, and some CBG or CBD products sold in licensed stores pair them with meaningful THC. Read the THC milligrams on every label. For how both compare with THC itself, see CBD vs. THC.

Using CBG and CBD together, and reading ratio labels

Some products blend the two, often alongside THC or other cannabinoids. A label might read CBD:CBG 1:1 or list the milligrams of each per serving. Here's how to read it:

• Ratios show balance, not strength. A 1:1 tincture could hold 5 mg of each per serving, or 25 mg.
• Check the THC. In a licensed product, the THC milligrams decide how intoxicating it is.
• Count the totals. Add up the milligrams of every cannabinoid you take in a day.

Research hasn't established whether CBG and CBD work better together than apart. The broader idea that cannabis compounds boost one another, often called the entourage effect, is still debated. CBD's known drug interactions and liver effects are reason enough to run any blend past a pharmacist first.

CBG vs CBD comparison table

Licensed Michigan stores serve adults 21 and older and registered patients 18 and older. Enjoy cannabis responsibly.